{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:50:24Z","timestamp":1793767824722,"version":"4.6.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011879","name":"California Public Utilities Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1053\/j.gastro.2020.06.090","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T12:16:47Z","timestamp":1594815407000},"page":"1526-1532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":213,"title":["AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review"],"prefix":"10.1053","volume":"159","author":[{"given":"Eamonn M.M.","family":"Quigley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2020.06.090_bib1","first-page":"28","article-title":"Blind loop syndrome","volume":"52","author":"Card","year":"1959","journal-title":"Proc R Soc Med"},{"key":"10.1053\/j.gastro.2020.06.090_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1172\/JCI105289","article-title":"Studies on the pathogenesis of steatorrhea in the blind loop syndrome","volume":"44","author":"Donaldson","year":"1965","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2020.06.090_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0016-5085(69)80067-3","article-title":"Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons","volume":"56","author":"Drasar","year":"1969","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.06.090_bib4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gut.10.10.812","article-title":"Studies on the intestinal flora. II. Bacterial flora of the small intestine in patients with gastrointestinal disorders","volume":"10","author":"Drasar","year":"1969","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2020.06.090_bib5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0016-5085(71)80039-2","article-title":"Intestinal microflora","volume":"60","author":"Gorbach","year":"1971","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.06.090_bib6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0016-5085(79)91337-4","article-title":"Small intestine bacterial overgrowth","volume":"76","author":"King","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.06.090_bib7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(77)90436-6","article-title":"Bacterial overgrowth syndrome without \u201cblind loop\u201d: a cause for malnutrition in the elderly","volume":"2","author":"Roberts","year":"1977","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2020.06.090_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJM196907172810303","article-title":"Production and excretion of hydrogen gas in man","volume":"281","author":"Levitt","year":"1969","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2020.06.090_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(76)92779-3","article-title":"Breath-hydrogen test for small-intestinal bacterial colonisation","volume":"1","author":"Metz","year":"1976","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2020.06.090_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ajg.2017.46","article-title":"Hydrogen and methane-based breath testing in gastrointestinal disorders: The North American Consensus","volume":"112","author":"Rezaie","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.06.090_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41575-019-0171-5","article-title":"Symptoms and the small intestinal microbiome\u2014the unknown explored","volume":"16","author":"Quigley","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.06.090_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14309\/ajg.0000000000000501","article-title":"ACG clinical guideline: small intestinal bacterial overgrowth","volume":"115","author":"Pimentel","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.06.090_bib13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2036.2011.04625.x","article-title":"Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture","volume":"33","author":"Choung","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2020.06.090_bib14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2020.06.090_bib15","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s10620-019-05887-x","article-title":"Obesity and risk of small intestine bacterial overgrowth: a systematic review and meta-analysis","volume":"65","author":"Wijarnpreecha","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2020.06.090_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cgh.2009.06.031","article-title":"Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis","volume":"7","author":"Ford","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.06.090_bib17","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/s41467-019-09964-7","article-title":"Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders","volume":"10","author":"Saffouri","year":"2019","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2020.06.090_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000116777","article-title":"Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth","volume":"26","author":"Montalto","year":"2008","journal-title":"Dig Dis"},{"key":"10.1053\/j.gastro.2020.06.090_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.autrev.2015.01.018","article-title":"Fecal calprotectin in systemic sclerosis and review of the literature","volume":"14","author":"Marie","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.gastro.2020.06.090_bib20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MCG.0000000000000803","article-title":"Small-Intestinal bacterial overgrowth is associated with concurrent intestinal inflammation but not with systemic inflammation in Crohn's disease patients","volume":"52","author":"Ricci","year":"2018","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2020.06.090_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-223531","article-title":"Small intestinal bacterial overgrowth (SIBO) and vitamin K-responsive coagulopathy: a previously unrecorded association","volume":"2018","author":"Oliveira","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.gastro.2020.06.090_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2009.11.032","article-title":"Small intestinal bacterial overgrowth and warfarin dose requirement variability","volume":"126","author":"Giuliano","year":"2010","journal-title":"Thromb Res"},{"key":"10.1053\/j.gastro.2020.06.090_bib23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10620-007-0065-1","article-title":"A\u00a0systematic review of diagnostic tests for small intestinal bacterial overgrowth","volume":"53","author":"Khoshini","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2020.06.090_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12866-019-1617-1","article-title":"Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study","volume":"19","author":"Leite","year":"2019","journal-title":"BMC Microbiol"},{"key":"10.1053\/j.gastro.2020.06.090_bib25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0016-5085(19)36776-9","article-title":"4 - First large scale study defining the characteristic microbiome signatures of small intestinal bacterial overgrowth (SIBO): detailed analysis from the Reimagine study","volume":"156","author":"Leite","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.06.090_bib26","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s10620-011-1590-5","article-title":"Methane on breath testing is associated with constipation: a systematic review and meta-analysis","volume":"56","author":"Kunkel","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2020.06.090_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2020.06.090_bib28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","article-title":"Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.06.090_bib29","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.14309\/ajg.0000000000000444","article-title":"Lactulose breath testing as a predictor of response to rifaximin in patients with irritable bowel syndrome with diarrhea","volume":"114","author":"Rezaie","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.06.090_bib30","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/rheumatology\/key175","article-title":"Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review","volume":"57","author":"Pittman","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.gastro.2020.06.090_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.gtc.2017.09.008","article-title":"Small intestinal bacterial overgrowth: nutritional implications, diagnosis, and management","volume":"47","author":"Adike","year":"2018","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.gastro.2020.06.090_bib32","first-page":"111","article-title":"Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole","volume":"13","author":"Lauritano","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1053\/j.gastro.2020.06.090_bib33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MAJ.0b013e3180536784","article-title":"Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth","volume":"333","author":"Majewski","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.gastro.2020.06.090_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10620-007-9839-8","article-title":"Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS","volume":"53","author":"Yang","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2020.06.090_bib35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MCG.0b013e3181c64c90","article-title":"A\u00a0combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test","volume":"44","author":"Low","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2020.06.090_bib36","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1572-0241.2008.02030.x","article-title":"Small intestinal bacterial overgrowth recurrence after antibiotic therapy","volume":"103","author":"Lauritano","year":"2008","journal-title":"Am J Gastroenterol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508520349283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508520349283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:47:59Z","timestamp":1762163279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508520349283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0016508520349283"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2020.06.090","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2020.06.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}